Day 1 Wednesday, November 18

08:45-08:55

Opening

Organizers

08:55-09:00

Chair

Takanori Yokota, MD, PhD

09:00-09:45

Keynote

Eric D. Green, MD, PhD, Director, National Human Genome Research Institute (NHGRI), NIH, USA
Title: Human genomics, precision medicine, and advancing human health

09:45-10:15

Oleg Iartchouk, PhD, Global Head of Genomics, Novartis, USA
Title: NGS in drug discovery research

10:15-10:45

Tea Break

10:45-11:15

Todd Lowe, PhD, Professor, University of California Santa Cruz, USA
Title: Unraveling the complex roles for 500+ human tRNA genes and the ubiquitous, overlooked
tRNA fragments

11:15-11:45

Mark A. Kay, MD, PhD, Professor, Stanford University School of Medicine, USA
Title: New adeno associated vector (AAV) approaches for episomal and site-specific integration
based gene/RNAi therapeutics

11:45-12:00

Technology

Huanming Yang, PhD, Professor and Chairman, BGI, China
Title: From the HGP to “Precision Medicine”

12:00-13:30

Lunch

13:30-13:35

Chair

Laura Sepp-Lorenzino, PhD

13:35-14:20

Keynote

Jack W. Szostak, PhD, Professor, Harvard Medical School, 2009 Nobel Prize Winner, USA
Title: The origins of cellular life

14:20-14:50

Takanori Yokota, MD, PhD, Professor, Tokyo Medical and Dental University, Japan
Title: DNA/RNA heteroduplex oligonucleotide - a novel concept of therapeutic oligonucleotides

14:50-15:20

Tea Break

15:20-15:50

Seyed M. Moghimi, PhD, Professor, University of Copenhagen, Denmark
Title: Integrative nanomedicine: phage-derived peptidic assemblies for therapeutic nucleic acid
delivery targeting two receptors

15:50-16:20

Daniel G. Anderson, PhD, Professor, Massachusetts Institute of Technology, USA
Title: Nucleic acid delivery systems for RNA therapy and gene editing

16:20-16:50

A. Robert Macleod, PhD, Vice President, Isis Pharmaceuticals, USA
Title: Next generation constrained ethyl (cEt) antisense oligonucleotide inhibitors for therapeutic
targeting of extra hepatic tissues including tumors

16:50-17:00

Day End

Organizers

Day 2 Thursday, November 19

08:50 - 09:00

Chair

Nikolaus Rajewsky, PhD

09:00-09:45

Keynote

Craig C. Mello, PhD, Professor, University of Massachusetts, 2006 Nobel Prize Winner, USA
Title: RNA guided genome surveillance

09:45-10:15

Michael P. Terns, PhD, Professor, University of Georgia, USA
Title: CRISPR-Cas: small RNA mediated prokaryotic immune systems

10:15-10:45

Tea Break

10:45-11:15

Udi Qimron, PhD, Professor, Tel Aviv University, Israel
Title: CRISPR/Cas-encoding bacteriophages programmed to sensitize and kill antibiotic-resistant
bacteria

11:15-11:45

Joanne Kamens, PhD, Executive Director, Addgene, USA
Title: Trends in CRISPR technologies: data from Addgene’s plasmid repository

11:45-12:00

Technology

Xingwang Fang, PhD, Thermo Fisher Scientific, USA
Title: Sample prep for next generation molecular testing

Xiquan Liang, PhD, Thermo Fisher Scientific, USA
Title: Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection

12:00-13:30

Lunch

13:30-13:35

Chair

Mark A. Kay , MD, PhD

13:35-14:20

Keynote

Thomas A. Steitz, PhD, Professor, Yale University, 2009 Nobel Prize Winner, USA
Title:From the structure and function of the ribosome to new antibiotics

14:20-14:50

Nikolaus Rajewsky, PhD, Professor, Max Delbrück Center for Molecular Medicine, Germany
Title: Regulatory RNAs

14:50-15:20

Tea Break

15:20-15:50

Zhou Songyang, PhD, Professor, Sun Yat-sen University, China; Baylor College of Medicine, USA
Title: Gene editing in mouse and human cells

15:50-16:20

Dong-ki Lee, PhD, Professor, Sungkyunkwan University, South Korea
Title: Therapeutic development using the second generation RNAi triggers

16:20-16:50

Laura Sepp-Lorenzino, PhD, Vice President, Alnylam Pharmaceuticals, USA
Title: Hepatocyte targeted RNAi therapeutics: case studies in rare diseases and hepatitis B

16:50-17:00

Closing

截至6月30日

7月1日至9月30日

10月1日起

学生

¥800.00

¥1,000.00

¥1,400.00

学者

¥1,200.00

¥1,400.00

¥1,800.00

企业界

¥2,000.00

¥2,200.00

¥2,600.00